http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017296117-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f9b0a5a62d169b27b870c5ed2bd23ad
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2021-0044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2021-0077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06V40-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0663
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M21-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
filingDate 2017-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_721d2cf2c1c345e8f8c0a2a8094b181d
publicationDate 2017-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2017296117-A1
titleOfInvention Methods for preventing and treating motor-related neurological conditions
abstract Methods for preventing or treating motor-related neurological conditions include using ocular light therapy in connection with a conventional therapy for a motor-related neurological condition, such as a drug regimen, to adjust levels of melatonin and/or dopamine in the body of a subject. The ocular light therapy may include elevated levels of blue-green light or green light (e.g., light within a wavelength range of 460 nm to 570 nm, 490 nm to 570 nm, about 520 nm to 570 nm, etc.). The ocular light therapy may also include reduced levels of amber, orange and/or red light. Methods for diagnosing motor-related neurological conditions include use of ocular light therapy to cause a subject to temporarily exhibit one or more symptoms of any motor-related neurological condition to which the subject is predisposed, or which the subject may already be experiencing. A temporary increase in such symptoms may be effected by ocular administration of light including increased amounts of amber, orange and/or red light.
priorityDate 2007-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID951
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID184946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408881
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID184946
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11240
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18599
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID51702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18600
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18602

Total number of triples: 46.